Life Science Tools and Technologies for Bio-Pharma R&D - Instruments, Tech Platforms, Informatics and Market
Takeda Pacific
March 1, 2003 155 Pages - SKU: TAK1090289
|
|
|
This market research report is about the important market for life science tools & techs that are used for accelerating the research processes and capabilities of biopharmaceutical R&D. This key research information is valuable and offers readers a detailed overview of the size and shape of the life science tools and techs market and what the products can do to facilitate the advancement of pharmaceutical and biotech drug R&D programs.
Significant life science industry information is presented and reviewed. While pharmaceutical industry generated more than $255 billion in 2002, pharma companies are facing many important issues that could be helped by using new life science tools and technologies. A broad range of industry data is analyzed and reveals that pharma companies have seen their R&D costs dramatically increase over the last twenty years, while their product productivity has declined. In addition, many existing and profitable blockbuster drugs will reach patent expiration dates between 2005-2006. This situation will attract competition from generic or other branded drug makers. It shows that there is a clear need driving the desire for more innovation.
For buyers and sellers of life science tools and techs, this report shows that major pharma companies have increasingly become a source of significant strategic alliance opportunities for many of the companies that comprise the US biotechnology industry. Major pharma companies are motivated to become customers and partners of life science tools companies because the many "tools" companies offer technologies that enable them become more productive, reduce bottlenecks and deliver more marketable products, at less cost, and in a shorter time than in the current 10 to 15-year sequential drug development timeline.
Industrialization of pharmaceutical and biotech R&D has begun. These firms are using genomics and proteomics technologies, and other life science tools that can help these companies reach their drug product objectives. The report discusses some of the newest life science tools and tech advancements including nanobiotechnology, rolling circle amplification technology (RCAT), ICAT, RNAi, phage display, yeast 2 hybrid, PROfusion technology, surface plasmon resonance, biochips, protein arrays, separation technologies, 2D PAGE, HPLC, TOF/TOF, drug target discovery and validation tools among others.
This report has found that the life science tools & techs market size in 2002 was about $1.6 billion and is projected to more than double to about $3.5 billion by 2007, growing at a CAGR of 17.7%. While the economy is currently challenging this market, a pickup in growth is expected after 2004. Readers will learn about key business opportunities and the lessons learned from the life science tools and techs companies. This 155-page study uses 34 figures and tables to illustrate the research findings. Participating companies are mapped against multiple technologies to show where they fit in the competitive landscape. Over 27 life science tools & tech companies are profiled, and the report provides insights about the "tools & techs" that these interesting companies offer, including their strategies, funding and so on.
|
1.Overview of the Life Science Tools & Technology Market
The Competitive Marketplace
Analytical Instrumentation Companies
Genomics Companies
Proteomics Companies
Bioinformatics Software Companies
BioDatabase Companies
Drug Discovery Companies
Emerging Tools & Technology Companies
Reagent and Consumables Companies
Overview of Life Science Tool & Tech Developments
Gene Sequencing Systems
Protein Separation Tools
Mass Spectrometers (MS)
Microarray and Microfluidic Analytical Technologies
Emerging Technologies
Informatics - IT for Life Science R&D
Life Science Tool & Tech Applications for R&D
Biopharmaceutical Drug Discovery
R&D Diagnostic Tools
Pharming Applications
2.Factors Driving Life Science Tools & Tech Developments
The Opportunity to Make Multi-Billion Dollar Revenues
The Pace of Pharmaceutical Mergers and Acquisitions
Rapid Pace of Scientific Advancements
Economics of Pharmaceutical R&D
Drug Discovery R&D
Creation of Post-Genomic Era R&D Databases
Proteomics R&D Requires New Tools & Techs
3.Strategies for Life Science Tools & Techs for R&D
Business Models and Intellectual Property
Business Models
Intellectual Property (IP)
Commercializing Life Science Tools & Techs.
Develop and Out-License Technology
Produce and Sell Consumable Products for R&D
Produce and Sell Equipment Platforms to R&D Customers
Discover or Validate Drug Targets for Drug Discovery
Strategic Goals
Establish Customer Base with Large Pharmas or Biotechs
Make Key Alliances or Partnerships
Grow the Company to Reach Critical Mass
Business Development Strategies
Traditional Alliance Partnering
Become a Technology Roll-up
Merge with Another Biotech
4.Market Forecast
Life Science Tools & Tech R&D Market Size by Segment, 2002~2007
5.Activities of Analytical Instrument Companies
Affymetrix, Inc.
Agilent Technologies, Inc. (Life Sciences)
Cepheid
Ciphergen Biosystems, Inc.
6.Activities of Bioinformatics Companies
Accelrys, Inc (Subsidiary of Pharmacopeia Inc.)
Celera Genomics Corporation
Gene Logic, Inc.
Human Genome Sciences, Inc.
Incyte Corporation
InforMax, Inc. (Acq. by Invitrogen)
Spotfire, Inc.
7.Activities of Drug Discovery Tools Companies
AVIVA Biosciences
Caliper Technologies Corporation
Fluidigm Corporation
GeneMachines, Inc.
Nanogen, Inc.
8.Activities of Emerging Technology Companies
BioTrove
Illumina, Inc.
Nanostream
PamGene
Xeotron Corporation
Zyomyx, Inc.
9.Activities of Reagent & Consumables Companies
ACLARA BioSciences, Inc.
Genicon Sciences Corporation
Invitrogen Corporation
Molecular Staging, Inc.
Phylos, Inc.
Quantum Dot Corporation
10.Future Directions of Life Science Tools for R&D
Future Directions
Review of Recent Trends
Recent Developments in Genomics That Impact Life Science Tools
Indicators of Future Trends
Financing Volatility
Biotechnology Conferences
University Labs at Work
Bioinformatics Software.
Bioinformatics Databases
Emerging Protein Technology
Nanobiotechnology Opportunities Emerging
11.Conclusions and New Opportunities
Factors for Success or Failure
Highlights of Hot Development Areas of Life Science Tools
Life Science Tools & Tech Opportunities
Industrial Scale Proteomics
The Trend Towards Individualized Medicine
Summary
12.Appendix A. Tech Map of Industry Segments
Target Identification Genomic Technologies
Target Identification Protein Technologies
Protein Chip
Protein Databases
Target Validation
Drug Lead Screening
Preclinical Development
Phase I-III Clinical Development & Diagnostics
13.Appendix B. Technology Map Tables - Life Science Tools & Tech
Companies
14.Appendix C. Life Science Glossary
List of Tables
Table 1. Estimated Total Life Science Tools & Techs. Market Size
by Segment Revenues
Table 2. Total Life Science Tools & Tech Market Segments by
Market Share Percent
Table 3. Drug Discovery Tools Segment by Revenues
Table 4. Bioinformatics Tools Segment by Revenues
Table 5. Reagents and Consumables Segment by Revenues
Table 6. Emerging Technologies Segment by Revenues
Table 7. Future Directions of Life Science Tools & Techs for R&D
Table 8. Major Drug Discovery Tools Companies
Table 9. Major Bioinformatics Tools Companies
Table 10. Major Life Science Reagent & Consumables Vendors
Table 11. Major Emerging Technologies Companies
Table 12. Major Drug Discovery Companies
List of Figures
Figure 1. Life Science Tools & Techs Vendor Market
Figure 2. The R&D Path to Make Drug Products
Figure 3. Liquid Handling Systems
Figure 4. Incyte's Protein Expression Analysis Software
Figure 5. ScreenMate Products for HTS in Drug Lead R&D
Figure 6. Rolling Circle Amplification Technology (RCAT)
Figure 7. RNA Interference: Steps to Making siRNA
Figure 8. The InforMax ProChart™ for Protein Visualization
Figure 9. Computer Model using PhysioLab Technology
Figure 10. Big Pharma and Big Biotech Drug R&D Timeline
Figure 11. Using Parallel Processes to Increase Drug Discovery Productivity
Figure 12. Estimated Total Life Science Tools & Techs Market Size by Revenues
Figure 13. Estimated Total Life Science Tools & Tech Market Size
by Segment Revenues, 2002-2007
Figure 14. Comparison of Estimated Total Life Science Tools & Tech Market
Size by Segment Revenues, 2002-2007
Figure 15. Comparison of Segment Market Shares for the Life Science
Tools & Tech Market, 2002 and 2007
Figure 16. Drug Discovery Tools Segment by Revenues
Figure 17. Bioinformatics Tools Segment by Revenues
Figure 18. Reagents and Consumable Life Science Tools Segment by Revenues
Figure 19. Emerging Technologies Segment by Revenues
Figure 20. Spotfire DecisionSite
Figure 21. Accelrys GCG Wisconsin Package - SeqLab
Figure 22. The Incyte/ Oxford Glycoscience Proteome Analysis Process
Figure 23. Life Science Tools & Techs Opportunity Map
Share this report
Other tasks Related Markets Biopharmaceuticals Reports Free Alert Me service Receive bi-weekly email alerts on new market research Sign Up Today!
|
